Search - tctmd.com

Displaying 101 - 120 of 1475

Sort: Relevancy | Date

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

Presenter: Michaella Alexandrou

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

My Personal Guide to Prevention and Management of Equipment Disasters

Presenter: R. Michael Wyman

October 29, 2024

Presentation TCT 2024

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Presenter: C. Michael Gibson

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

ORBITA2-PHYSIOLOGY: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

Presenter: Michael Foley

October 27, 2024

Presentation TCT 2024

TCT 552: Impact of Calcium on the Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention (PROGRESS-BIFURCATION)

Presenter: Michaella Alexandrou

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Incorrect Arm Positions Overestimate Blood Pressure Measurements

Michael O'Riordan

October 08, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

Advertisement

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

My Personal Guide to Prevention and Management of Equipment Disasters

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

ORBITA2-PHYSIOLOGY: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

TCT 552: Impact of Calcium on the Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention (PROGRESS-BIFURCATION)

What’s Going to Be Big at TCT 2024?

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

MACE in CV Trials: Has the Outcome Outlived Its Role?

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Will Semaglutide Change Cardiac Surgery? It Already Has

Incorrect Arm Positions Overestimate Blood Pressure Measurements

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content